Advanced search
Publication Cover
Cancer Investigation Volume 9, 1991 - Issue 5
Submit an article Journal homepage
18
Views
18
CrossRef citations to date
0
Altmetric
Miscellaneous Article

The Immunotherapy of Human Cancer with Interleukin 2: Present Status and Future Directions

Jonathan E. Kolitz Hematology and Leukemia Services Division of Hematologic Oncology Department of Medicine Memorial Sloan-Kettering Cancer Center and Cornell University Medical College New York, New York; Department of Hematology, University of Freiburg Freiburg, Federal Republic of Germany
&
Roland Mertelsmann Hematology and Leukemia Services Division of Hematologic Oncology Department of Medicine Memorial Sloan-Kettering Cancer Center and Cornell University Medical College New York, New York; Department of Hematology, University of Freiburg Freiburg, Federal Republic of Germany
Pages 529-542 | Published online: 11 Jun 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

A. Block & H. Greten. (1998) Adenoviral gene therapy of gastrointestinal tumour metastases in the liver. Minimally Invasive Therapy & Allied Technologies 7:6, pages 559-566.
Read now
W. Budzynski & C. Radzikowski. (1994) Cytotoxic Cs in Immunodeficient Athymic Mice. Immunopharmacology and Immunotoxicology 16:3, pages 319-346.
Read now

Articles from other publishers (16)

Kathryn T. Ciccolini, Katharina C. Kaehler, Mario E. Lacouture & Axel Hauschild. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology 233 240 .
K E Zucker, P Kamberi, R A Sobel, G Cloud, D N Meli, K V Clemons, D A Stevens, P L Williams & S L Leib. (2006) Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis. Clinical and Experimental Immunology 143:3, pages 458-466.
Crossref
Bok Y. Kang, Young S. Lim, Su W. Chung, Eui J. Kim, Seung H. Kim, Seung Y. Hwang & Tae S. Kim. (1999) Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintainedin vivo by re-stimulation with an antigen/interleukin-2 fusion protein. International Journal of Cancer 82:4, pages 569-573.
Crossref
Robin Thorpe. 1998. Cytokines. Cytokines 19 33 .
T. Osaki, E. Ueta, K. Yoneda & T. Yamamoto. (2008) Intranodal injection of anticancer drugs into fixed cervical metastatic lymph nodes. Oral Diseases 3:4, pages 247-253.
Crossref
Julie Brittenden, S. D. Heys, J. Ross & O. Eremin. (1996) Natural killer cells and cancer. Cancer 77:7, pages 1226-1243.
Crossref
Gary R. Peplinski, Kangla Tsung, Eric D. Whitman, Jennifer B. Meko & Jeffrey A. Norton. (1995) Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1β. Annals of Surgical Oncology 2:2, pages 151-159.
Crossref
Jill K. Bruton & Jim M. Koeller. (2012) Recombinant Interleukin‐2. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 14:6, pages 635-656.
Crossref
Lynn P. Courtney, Julia L. Phelps & Linda M. Karavodin. (1994) An anti-IL-2 antibody increases serum halflife and improves anti-tumor efficacy of human recombinant interleukin-2. Immunopharmacology 28:3, pages 223-232.
Crossref
Alexander L. Rakhmilevich & Robert J. North. (1994) Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the antitumor action of interleukin-2. Cancer Immunology Immunotherapy 38:2, pages 107-112.
Crossref
Albrecht Lindemann, Peter Brossart, Klaus H�ffken, Michael Fla�hove, Dimitris Voliotis, Volker Diehl, Georg Hecker, Herrmann Wagner & Roland Mertelsmann. (1993) Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study. Cancer Immunology Immunotherapy 37:5, pages 307-315.
Crossref
Thomas A. Waldmann. (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunology Today 14:6, pages 264-270.
Crossref
Thomas A. Waldmann. (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Trends in Pharmacological Sciences 14:5, pages 159-164.
Crossref
Mark A. Israel. 1993. 57 85 .
E Tartour, C Mathiot & WH Fridman. (1992) Current status of Interleukin-2 therapy in cancer. Biomedicine & Pharmacotherapy 46:10, pages 473-484.
Crossref
Bruno Osterwalder. 1992. Lymphohaematopoietic Growth Factors in Cancer Therapy II. Lymphohaematopoietic Growth Factors in Cancer Therapy II 57 86 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.